<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02650531</url>
  </required_header>
  <id_info>
    <org_study_id>2015/171/REK nord</org_study_id>
    <nct_id>NCT02650531</nct_id>
  </id_info>
  <brief_title>Norwegian COgnitive Impairment After STroke (NorCOAST) Study</brief_title>
  <acronym>Nor-Coast</acronym>
  <official_title>Norwegian COgnitive Impairment After STroke (NorCOAST) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vestre Viken Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective observational multicenter study aiming to describe incidence, and identify
      predictors for development of poststroke dementia (PSD) and mild cognitive impairment (MCI)
      after stroke
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      About 15000 Norwegians suffer a stroke every year and 2/3 will be more or less disabled. In
      addition to motor impairments and comorbidities, disability after stroke is often related to
      post stroke dementia (PSD) or mild neurocognitive disorder (NCD). However, these problems are
      hardly addressed in stroke or dementia research and frequently ignored in clinical practise.
      In the Nor-COAST study an interdisciplinary research group will collaborate to establish a
      research platform across all Norwegian Health Authorities. The overall aim of the study is to
      improve competence on PSD and NCD in order to improve individual health outcomes following a
      stroke. The specific objectives are to determine the incidence of PSD and NCD and the
      consequences on function and use of health care services and to enhance the early detection
      of PSD and NCD by identifying a set of risk factors, ranging from genetics to physical
      activity. The incidence and impact of PSD and NCD on function and use of health care
      services, medication and life-style changes are important when planning future health care
      services. Tools identifying patients at risk might improve diagnostic work up and together
      with knowledge on pathogenic aspects it will contribute to future treatment and prevention of
      PSD and NCD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">October 8, 2018</completion_date>
  <primary_completion_date type="Actual">October 8, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Score on the Montreal cognitive assessment (MOCA)</measure>
    <time_frame>18 months</time_frame>
    <description>Performance based test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score on the Montreal cognitive assessment (MOCA)</measure>
    <time_frame>3 months</time_frame>
    <description>Performance based test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in upright position</measure>
    <time_frame>3 months</time_frame>
    <description>measured by bodyworn sensors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in upright position</measure>
    <time_frame>18 months</time_frame>
    <description>measured by bodyworn sensors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain Imaging</measure>
    <time_frame>18 months</time_frame>
    <description>MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on Short Physical Performance Battery (sppb)</measure>
    <time_frame>3 months</time_frame>
    <description>Performance based test for mobility and lower extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on Short Physical Performance Battery (sppb)</measure>
    <time_frame>18 months</time_frame>
    <description>Physical function by performance based tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selfreported habits concerning smoking, alcohol, diet and medication using standardised questionnaires</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selfreported habits concerning smoking, alcohol, diet and medication using standardised questionnaires</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">816</enrollment>
  <condition>Dementia</condition>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Stroke</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute stroke
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stroke diagnosis according to the WHO criteria

        Exclusion Criteria:

          -  Not scandinavian speaking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Jacob Stovner, md prof</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Norwegian University of Science and Technology</name>
      <address>
        <city>Trondheim</city>
        <zip>7006</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Thingstad P, Askim T, Beyer MK, Bråthen G, Ellekjær H, Ihle-Hansen H, Knapskog AB, Lydersen S, Munthe-Kaas R, Næss H, Pendlebury ST, Seljeseth YM, Saltvedt I. The Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort study. BMC Neurol. 2018 Nov 26;18(1):193. doi: 10.1186/s12883-018-1198-x.</citation>
    <PMID>30477436</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 10, 2015</study_first_submitted>
  <study_first_submitted_qc>January 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2016</study_first_posted>
  <last_update_submitted>December 3, 2019</last_update_submitted>
  <last_update_submitted_qc>December 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Follow up studies</keyword>
  <keyword>Risk factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

